# Design Therapeutics, Inc.: Form 8-K, filed Jun 7, 2021

- Company: [Design Therapeutics, Inc.](/companies/dsgn.md) (CIK 1807120)
- Form: 8-K
- Filed: 2021-06-07
- Accepted by EDGAR: Jun 7, 2021, 16:26 ET
- Period: 2021-06-03
- Accession: 0001564590-21-031964
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1807120/000156459021031964/dsgn-8k_20210603.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1807120/000156459021031964/

## Items reported

- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1807120/000156459021031964/dsgn-8k_20210603.htm

Filed Jun 7, 2021.
Source: SEC EDGAR, the filing index for accession 0001564590-21-031964. Last ingested by Listed: Nov 14, 2026, 10:50 ET. No prices; not investment advice.
